ES
31
3
AN
54
4
COP
54
-2
KMX
64
6
O
22
2
HPQ
57
-2
DRI
48
3
GILD
49
2
EXPE
91
3
HP
45
4
FRT
45
6
AVGO
22
2
AAL
53
-4
SLG
66
2
UA
59
14
CPB
24
2
ALLE
44
7
WDC
43
2
CVS
50
2
RIG
58
4
ES
31
3
AN
54
4
COP
54
-2
KMX
64
6
O
22
2
HPQ
57
-2
DRI
48
3
GILD
49
2
EXPE
91
3
HP
45
4
FRT
45
6
AVGO
22
2
AAL
53
-4
SLG
66
2
UA
59
14
CPB
24
2
ALLE
44
7
WDC
43
2
CVS
50
2
RIG
58
4
Financhill
Back

Regenxbio Vs. Catalyst Pharmaceuticals Industry Stock Comparison

Sell
18

RGNX
Regenxbio

Last Price:
9.21
Seasonality Move:
-5.66%
Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
21.13
Seasonality Move:
4.48%
Sell
18
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $9.18. The Score for RGNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $9.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.12
    The current trend is moderately bearish and CPRX is experiencing slight buying pressure.

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 43.02 Sell
Chaikin Money Flow: -473643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.97 - 10.71) Sell
Bollinger Bands (100): (9.86 - 12.8) Sell

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 45.27 Sell
Chaikin Money Flow: 380001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.02 - 22.7) Sell
Bollinger Bands (100): (17.53 - 21.69) Buy

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.06 Sell
20-day SMA: 9.77 Sell
50-day SMA: 10.34 Sell
200-day SMA: 14.27 Sell
8-day EMA: 9.84 Sell
20-day EMA: 9.96 Sell
50-day EMA: 10.39 Sell
200-day EMA: 13.22 Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.58 Sell
20-day SMA: 22 Sell
50-day SMA: 21.09 Buy
200-day SMA: 17.53 Buy
8-day EMA: 21.5 Sell
20-day EMA: 21.69 Sell
50-day EMA: 21.05 Buy
200-day EMA: 18.22 Buy

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):